Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (385)	5/31/2001 11:31:16 AM
From: Extra Pale	Read Replies (1) \| Respond to of 438

maybe this explains the recent rise in gzmo -- conference insiders buying stock: siliconinvestor.com GZMO : GENZYME MOLECULAR ONCOLOGY (NASDAQ) All Headlines Genzyme Reports Progress in Gene Therapy Program CAMBRIDGE, Mass., May 31, 2001 /PRNewswire via COMTEX/ -- Scientists from Genzyme Corp. will present 17 papers at the American Society of Gene Therapy's fourth annual meeting in Seattle this week. The presentations update progress made across the company's broad gene therapy research program, which is investigating potential treatments for genetic diseases, cardiovascular disease and cancer. (snip)